IFNG and inflammatory bowel disease: For example, many pathogenic cytokines (IL-13, IL-23, and IFN-γ) are transmitted through the Janus kinase and transcriptional signal converter and activator (JAK/STAT) signaling pathway, so JAK inhibitors (tofacitinib) can be used clinically to treat IBD.